[Press Release] MFDS, Published English Assessment Summaries of Locally Developed Biosimilars
- Registration Date 2023-12-22
- Hit 25444
- Two Home-grown Lucentis Biosimilars Added to List of English Assessment Summaries of MFDS-approved Biosimilars
The Ministry of Food and Drug Safety (Minister OH Yu-Kyoung) announced that the English assessment summary information of two Korean Lucentis biosimilars (ranibizumab)* to treat age-related macular degeneration was disclosed at the MFDS website.
* Amelivu inj. (Samsung Bioepis), Chong Kun Dang Ranibizumab inj. (Chong Kun Dang)
첨부파일
붙임
Division 유전자재조합의약품과
Written by 최예진
Telephone 043-719-3509